Alzheimer’s Disease Research Request for Proposals
Alzheimer’s Disease Research, a BrightFocus Foundation program, provides research funds for U.S. domestic and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer’s disease.
We are committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges and strongly encourage applications from individuals who are from groups underrepresented in Alzheimer’s disease research.
FY25 Dates & Deadlines
Letter of Intent
Closed
Full Application
Due December 20, 2024
By invitation only.
All deadlines are 5:00 p.m. EST (Washington, D.C.) on the day of the deadline.
About the Awards
Alzheimer’s Disease Research offers two types of awards:
Standard Awards
Must be allowed by institution to apply for and manage a grant award and mentor students.
The standard award provides significant funding for researchers who have already generated some amount of preliminary data but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies.
- Award Amount: $300,000
- Duration: 3 years
Postdoctoral Fellowship Awards
Must be within 5 years of degree conferral.
Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant’s independent research career.
- Award Amount: $200,000
- Duration: 2 years
Related News
A BrightFocus-Funded Non-Invasive Treatment Slows Alzheimer’s Progression in Yearlong Study
Sinaptica Therapeutics unveils breakthrough Phase 2 results for an experimental non-invasive treatment for Alzheimer’s disease.
Breaking News Dispatch: A Non-Invasive Alzheimer’s Treatment, Early Detection, and More
Get the latest in Alzheimer’s screening and treatments.
Could Finding and Treating Tiny Blood Clots in the Brain Delay Alzheimer’s?
A BrightFocus-funded scientist is investigating a novel imaging tool that could be used to find treatable blood clots in the brain and slow the progression of Alzheimer’s disease.
BrightFocus Workshop Helps Shape Future Alzheimer’s Leaders
Students and senior Alzheimer’s researchers gathered in Chicago for an immersive workshop hosted by BrightFocus Foundation.
Reduce Your Dementia Risk: Two New Risk Factors Identified
“It’s never too early in life or too late in life to reduce risk for dementia,” says Dr. Quincy Samus, a member of the Lancet Standing Commission on Dementia Prevention, Intervention, and Care. Learn more about two new ways to do so.
Treating the Heart, Protecting the Brain
Can controlling blood pressure curb mid-life Alzheimer’s risk? A BrightFocus-funded scientist investigates.
Why APOE4 Makes Women More Susceptible to Alzheimer’s
The Alzheimer’s risk gene APOE4 puts women at greater risk for Alzheimer’s disease than men. New research unveils a possible cause.
Breaking News Dispatch: Alzheimer’s International Conference
Catch up on a few of the top headlines from the 2024 Alzheimer’s Association International Conference.
Centenarian Study Uncovers Gene Variants That Shield Against Alzheimer’s
A new BrightFocus-funded study of cognitively healthy 100-year-olds sheds light on genetic characteristics that protect the brain.